Research Communication: Serum Metabolomic Signatures Predict Tumour Recurrence After Resection or Ablation in Patients With Early‐Stage Hepatocellular Carcinoma

by Cyrus Huneycutt | Oct 16, 2025 | 0 comments

Submit a Comment Cancel reply

You must be logged in to post a comment.